• Profile
Close

Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy

Urologic Oncology: Seminars and Original Investigations Apr 04, 2018

Ornstein MC, et al. - Researchers explored the association between MDSC, clinicopathologic factors, and pathologic response in patients with bladder urothelial carcinoma (UC). MDSC levels had statistically significant associations with pCR rates, absolute neutrophil-lymphocyte ratio, and histology. Tumor % M-MDSCs showed a negative association with lymphovascular invasion. Findings thereby suggest that blood and tissue MDSC levels have correlation with several clinicopathologic factors and may predict for pCR.

Methods

  • From patients with UC undergoing definitive surgery, peripheral blood or tissue were collected.
  • Researchers measured MDSCs levels in peripheral blood mononuclear cells and fresh tumor tissue.
  • Using flow cytometry, MDSCs were identified; these were defined as total MDSC (T-MDSC) CD33+/HLADR-.
  • Three subsets were identified from this population: polymorphonuclear-MDSC (PMN-MDSC) defined as CD33+/HLADR-/CD15+/CD14-, monocytic-MDSC (M-MDSC) defined as CD33+/HLADR-/CD15-/CD14+, and immature-MDSC (I-MDSC) defined as CD33+/HLADR-/CD15-/CD14-.
  • MDSC populations were presented as % of live nucleated blood cells.
  • They assessed correlations between MDSC populations, clinicopathologic factors, and pathologic complete response (pCR) using Spearman correlations (r) and Wilcoxon rank sum test.

Results

  • From February 2015 through Dec 2016, 85 patients [74 (87%) were men and a median age at diagnosis was 68 (range: 44–87)] scheduled to undergo cystectomy; these were included in this study.
  • All patients underwent blood analysis; 23 patients had residual tumor tissue collected for analysis at the time of surgery.
  • The most common histology was pure UC (75%); 28 (35%) patients had prior treatment with intravesical therapy and 36 (42%) were treated with neoadjuvant chemotherapy, primarily gemcitabine plus cisplatin (n = 24).
  • Eighteen (21%) of the patients had pCR, 11 (13%) had positive lymph nodes, and 20 patients (24%) had lymphovascular invasion on surgical pathology.
  • Between circulating MDSC levels and pCR rates (P < 0.01), absolute neutrophil-lymphocyte ratio (P=0.008), and histology (P=0.01) statistically significant associations were observed.
  • Tumor % M-MDSCs showed a negative association with lymphovascular invasion (P = 0.04).
  • Between peripheral blood mononuclear cells and tumor MDSC subtypes, no significant correlations were identified.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay